Jianmin Pharmaceutical Group Co Ltd. Stock Analysis 600976.SS

Jianmin Pharmaceutical Group Co., Ltd. engages in the research and development, manufacturing, wholesale and retail of pharmaceutical products. The company is headquartered in Wuhan, Hubei and currently employs 2,257 full-time employees. The company went IPO on 2004-04-19. The firm operates its businesses through two segments. The Pharmaceutical Production and Sales segment is primarily engaged in the production of various types of Chinese patent medicines and sales to pharmaceutical distributors at all levels, including sales to the commercial division within the group that sells to non-hospitals. The Commercial segment is primarily engaged in the purchase of drugs from manufacturers and manufacturers' agents, and then distribution to lower-level distributors, sales to hospitals and retail sales in pharmacies. The firm mainly operates its businesses in the domestic market.